Muscarinic M3 receptor coupling and regulation

Life Sciences

Volumn 60, Issue 13-14, 1997, Pages 1039-1045

  Nahorski, S R ^a   Tobin, A B ^a   Willars, G B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

G proteins; M3 receptors; muscarinic receptor regulation

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PILOCARPINE; PROTEIN KINASE; RECEPTOR SUBTYPE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC RECEPTOR;

CONFERENCE PAPER; HUMAN; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; PHYSIOLOGY; REVIEW;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; MUSCARINIC AGONISTS; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC;

EID: 0030609973     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00045-3     Document Type: Conference Paper

References (45)

1. M.P. CAULFIELD, Pharmacol. Therap. 58, 319-379 (1993).
2. C.C. FELDER, FASEB J. 9, 619-625 (1995).
3. M.J. BERRIDGE, Nature 361, 315-325 (1993).
4. H. HUG and T.F. SARRE, Biochem. J. 291, 329-343 (1993).
5. A. ASHKENAZI, J.W. WINSLOW, E.G. PERALTA, G.L. PETERSON, M.I. SCMERLIK, D.J. CAPON and J. RAMACHANDRAN, Science 238, 672-674 (1987).
6. E.G. PERALTA, A. ASHKENAZI, J.W. WINSLOW, J. RAMACHANDRAN and D.J. CAPON, Nature 334, 434-437 (1988).
7. M.A. BUCK and C.M. FRASER, Biochem/Biophys. Res. Commun. 173, 666-672 (1990).
8. M.L. DELL'ACQUA, R.C. CARROLL and E.G. PERALTA, J. Biol. Chem. 268, 5676-5685 (1993).
9. T.P. KENAKIN, Trends Pharmacol. Sci. 16, 188-192 (1995).
10. S. OFFERMANS and G. SCHULTZ, Naunyn-Schmiedebers Arch. Pharmacol. 350, 329-338 (1994).
11. T.P. KENAKIN and P.H. MORGAN, Mol. Pharmacol. 35, 214-222 (1989).
12. R.R. NEUBIG, FASEB. J. 8, 939-946 (1994).
13. N.T. BURFORD, A.B. TOBIN and S.R. NAHORSKI, Eur. J. Pharmacol. 289, 343-351 (1995).
14. S. OFFERMANS, T. WIELAND, D. HOMANN, J. SANDMANN, E. BOMBIEN, K. SPICHER, G. SCHULTZ and K.H. JAKOBS. Mol. Pharmacol. 45, 890-898 (1994).
15. N.T. BURFORD, A.B. TOBIN and S.R. NAHORSKI, J. Pharmacol. Exp. Therap. 274, 134-142 (1995).
16. Y. DAI, I.S. AMBUDKER, V.J. HERN, C.K. YEH, E.E. KOUSVERLARI, S.J. WALL, M. LI, R.P. YASUDA, B.B. WOLFE and B.J. BAUM, Am. J. Physiol. 261, C1063-C1073 (1991)
17. R. MISTRY, A. CARRUTHERS, S.R. NAHORSKI and R.A.J. CHALLISS, Brit. J. Pharmacol. 119, 4P (1996).
18. I. LITOSCH, Biochem. J. 319, 173-178 (1996).
19. D. GURWITZ, R. HARING, E. HELDMAN, C.M. FRASER, D. MANOR and A. FISHER, Eur. J. Pharmacol. 267, 21-51 (1994).
20. E. HELDMAN, J. BARG, A. FISHER, R. LEVY, Z. PITTEL, R. ZIMLICHMAN, M. KUSHNIR and Z. VOGEL, Eur. J. Pharmacol. 297, 283-291 (1996).
21. A.J. DELEAN, J.M. STADEL and R.J. LEFKOWITZ, J. Biol. Chem. 255, 7108-7117 (1980).
22. R.J. LEFKOWITZ, S. COTTECHIA and T. COSTA, Trends Pharmacol. Sci. 14, 303-307 (1993).
23. P. SAMAMA, G. PEI, T. COSTA, S. COTTECHIA and R.J. LEFKOWITZ, Mol. Pharmacol. 45, 390-394 (1994).
24. E.S. BURSTEIN, T.A. SPALDING, H. BRAUMER-OSBORNE and M.R. BRANN, FEBS Lett. 363, 261-263 (1995).
25. T. COSTA, Y. OGINO, P.J. MUNSON, O. ONARAN and D. RODBARD, Mol. Pharmacol. 41, 549-560 (1992).
26. G. HILF and K.H. JAKOBS, Eur. J. Pharmacol. 225, 245-252 (1992).
27. E.C. AKAM, R.A.J. CHALLISS and S.R. NAHORSKI, Brit. J. Pharmacol. 119, 6P (1996).
28. L.M.F. LEEB-LUNBERG, S.A. MATHIS and M.C.S. HERZIG, J. Biol. Chem. 269, 11687-11690 (1994).
29. M.J. SMIT, R. LEWS, A.E. ALLEWIJNSE, J. BLAUW, Y. VAN DE VREDE, E. REOVERS, E. and H. TIMMERMAN, Proc. Natl., Acad. Sci. USA. 93, 6802-6807 (1996)
30. J. JAKUBIK, L. BACAKOVÁ, E. EL FAKAHANY and S. TUCEK, FEBS Lett. 377, 275-279 (1995)
31. D.M. PEREZ, J. HWA, R. GALVIN, M. MATHUR, F. BROWN and R.M. GRAHAM, Mol. Pharmacol. 49, 112-122 (1996).
32. R.J.H. WOJCIKIEWICZ, A.B. TOBIN and S.R. NAHORSKI,Trends Pharmacol. Sci. 14, 279-285 (1993).
33. A.B. TOBIN, D.G. LAMBERT and S.R. NAHORSKI, Mol. Pharmacol. 42, 1042-1048 (1992).
34. R.J.H. WOJCIKIEWICZ, A.B. TOBIN and S.R. NAHORSKI, J. Neurochem. 63, 177-185 (1994).
35. R.J.H. WOJCIKIEWICZ, A.B. TOBIN, S.T. SAFRANY and S.R. NAHORSKI, Regulation of Cellular Signal Transduction by Desensitisation and Amplification, D.R. Sibley and M.D. Houslay (eds) 169-190, John Wiley & Sons, Chichester, U.K. (1994).
36. 2+ Signalling, M.K. Uchida (ed), 181-206 S. Karger, Basel. (1996)
37. A.B. TOBIN (ed) The Phospholipase C Pathway: Its Regulation and Desensitisation, 1-223, R.G. Landes Springer, Austin (1996).
38. S.R. NAHORSKI, C.I. RAGAN and R.A.J. CHALLISS, Trends Pharmacol. Sci. 12, 297-303 (1991).
39. S. JENKINSON, S.R. NAHORSKI and R.A.J. CHALLISS, Mol. Pharmacol. 46, 1138-1148 (1994).
40. S.K. FISHER, D.M. SLOWIEJKO and E.L. McEWEN, Neurochem. Res. 19, 549-554 (1994).
41. J.S. DAVIDSON, I.K. WAKEFIELD and R.P. MILLER, Biochem. J. 300, 299-302 (1994).
42. W.P. HAUSDORFF, M.G. CARON and R.J. LEFKOWITZ, FASEB. J. 4, 2881-2889 (1990).
43. A.B. TOBIN and S.R. NAHORSKI, J. Biol. Chem. 268, 9817-9823 (1993).
44. A.B. TOBIN, B. KEYS and S.R. NAHORSKI, FEBS Lett. 335, 353-357 (1993).
45. A.B. TOBIN, B. KEYS and S.R. NAHORSKI, J. Biol. Chem. 271, 3907-3916 (1996).